NASDAQ:ELYM
Delisted

Eliem Therapeutics Stock Signals

etoro logo Buy ELYM
*Your capital is at risk
$5.11
+0 (+0%)
At Close: Dec 31, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Eliem Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 61 days ( 0 %
Last Price $5.11 0 %
Performance History
7 Days
$5.11 $5.11
0%
30 Days
$5.11 $5.11
0%
12 Mos
$2.70 $5.11
89.26%

3/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $5.11 - $5.11
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 30, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Oct 17, 2024 - 52 days
Short MA 3 mos Sell Low Oct 07, 2024 - 60 days
Long MA 3 mos Sell Medium Nov 14, 2024 - 32 days
Short/Long MA 3 mos Sell Medium Nov 14, 2024 - 32 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.5
Signal Type Signal Value Importance Data
Trend - 12 mos 32.86 % Very High Width: 276.69 %
Pred. range - 12 mos $4.29 - $16.16 High -16.02 % - 216.33 %
Short MA 12 mos Sell Very High Oct 25, 2024 - 46 days
Long MA 12 mos Sell Very High Sep 23, 2024 - 70 days
Short/Long MA 12 mos Sell Very High Aug 22, 2024 - 91 days
Pivot Long Buy Low Sep 27, 2024 - 66 days
RSI Long Pivot Signal Sell Low Oct 28, 2024 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ELIEM THERAPEUTICS, INC.
Eliem Therapeutics
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE